Oral Obesity Treatment
-
{
- All
- News
'Oral Obesity Treatment' - 1 News Result(s)
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
'Oral Obesity Treatment' - 1 News Result(s)
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
